This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Focus on Anxiety Disorders

Section II: Focus on Anxiety Disorders


Published: October 1, 2003

Article Abstract
The increasing number of treatments approved for anxiety disorders has put remission
within reach for more patients than ever before. Remission is now a frequent end point
in clinical trials as well as the recommended goal in clinical practice. Measurement of
remission varies from study to study, however, as no single definition of remission has
yet become standard.

Studies of patients with anxiety disorders show that they are high utilizers of primary care
services. Despite this, a large percentage of patients remains undiagnosed and untreated.
People with undiagnosed anxiety disorders may be difficult to recognize in primary care,
particularly because they usually present with somatic complaints. To successfully recognize
and treat this population of patients, primary care physicians must become familiar with the
typical presentation of anxiety in their patients. In this supplement, psychiatrists discuss the
definition of remission, the neurobiology of anxiety disorders and mechanisms of action for
pharmacologic treatment, and describe methods of identifying patients with anxiety
disorders in the primary care setting.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 64

Quick Links: